CIK 0001477845 · Non-accelerated filer<br>Smaller reporting company
Annovis Bio, Inc.
Sign in to watch- Ticker
- ANVS
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 262540421
- Phone
- 484-875-3192
- Business address
- 101 LINDENWOOD DRIVE, SUITE 225, MALVERN, PA, 19355
- Former names
- QR Pharma, Inc.
- 8-K Event Regulation FD disclosure
- 4 Grant or award Vice President, Finance acquired 500 shares (grant or award)
- 4 Grant or award Director acquired 25,001 shares (grant or award)
- 4 Grant or award Director acquired 2,000 shares (grant or award)
- 4 Grant or award President & CEO acquired 46,000 shares (grant or award)
- 4 Grant or award Director acquired 5,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 8-K Event Results of operations · Executive or director change
- 10-Q Report Quarterly Report
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 8-K Event Delisting notice · Executive or director change · Regulation FD disclosure
- 10-K Report Annual Report
- 8-K Event Results of operations
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 8-K Event Regulation FD disclosure
- 8-K Event Material agreement · Other events
- 424B5 Offering Prospectus
Page 4 of 16 · 315 filings